Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays software revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T22:26:26.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The history now shows a new revision, v3.7.0, replacing the previous v3.6.6. This indicates an update to the study record.
    Difference
    0.1%
    Check dated 2026-09-19T22:17:28.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The record history shows an updated revision tag: v3.6.6 replaces the previous v3.6.5, indicating a metadata update to the study record. No substantive study data or content appears to be changed.
    Difference
    0.1%
    Check dated 2026-08-29T19:00:00.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A new revision entry is added: v3.6.5, signaling a newer version of the study record and replacing the previous v3.6.4 entry.
    Difference
    0.1%
    Check dated 2026-08-08T17:50:21.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A new platform revision (v3.6.4) is added to the history, while the previous revision (v3.6.3) is removed from the current listing, indicating a minor system update to the history page.
    Difference
    0.1%
    Check dated 2026-07-25T09:31:37.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    A new revision (v3.6.3) was added to the record history, while the earlier revision (v3.6.2) was removed from the history. This updates the documented versioning of the study record without altering its substantive content.
    Difference
    0.1%
    Check dated 2026-07-03T22:20:54.000Z thumbnail image

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.